![Paul McInulty](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Paul McInulty currently works at Arvinas, Inc., as Senior Vice President-Regulatory Affairs from 2022.
Mr. McInulty also formerly worked at Bristol Myers Squibb Co., as Vice President-Therapeutic Head & Hematology and Celgene Corp., as Vice President-Regulatory Affairs.
Mr. McInulty received his undergraduate degree from The University of Sheffield.
Aktiva positioner av Paul McInulty
| Företag | Position | Start |
|---|---|---|
| ARVINAS, INC. | Generell Rådgivare | 2022-10-03 |
Tidigare kända positioner av Paul McInulty
| Företag | Position | Slut |
|---|---|---|
| CELGENE | Generell Rådgivare | - |
| BRISTOL-MYERS SQUIBB COMPANY | Företagsledare/Principal | - |
Paul McInultys utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
29
Första gradens relationer
4
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
The University of Sheffield
 The University of Sheffield Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arvinas, Inc.
 Arvinas, Inc. BiotechnologyHealth Technology Engages in discovery, development and commercialization of therapies to degrade disease-causing proteins | Health Technology |
